Prime Medicine (PRME) announced the appointment of Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer, CBO. Most recently, Hawryluk served as Chief Business Officer at AIRNA Corporation
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRME:
- Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
- Prime Medicine price target raised to $5 from $4 at Citi
- PRME Earnings this Week: How Will it Perform?
- Cathie Wood Loads Up on Klarna, Synopsys, and Rubrik, Trims Shopify and Roblox Stocks
- Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today